Insulin glargine 300 safe, effective in seniors with T2DM

June 26, 2018

(HealthDay)—For older adults, insulin glargine 300 units/mL (Gla-300) is safe and as effective as Gla-100, with a similarly low or lower risk of symptomatic hypoglycemia, according to a study published online June 12 in Diabetes Care.

Robert Ritzel, M.D., from Städtisches Klinikum München GmbH in Munich, Germany, and colleagues conducted a multicenter trial involving , aged ≥65 years, designed to have about 20 percent of participants be aged ≥75 years. A total of 1,014 participants were randomly allocated to receive Gla-300 or Gla-100, titrated to a fasting self-monitored plasma glucose of 5 to 7.2 mmol/L.

The researchers found that from baseline to week 26, the reductions in HbA1c were comparable for Gla-300 and Gla-100 in the overall population and for participants aged ≥75 years. Similar and low incidence and rates of confirmed or severe hypoglycemia events were reported between the groups, with lower rates of documented symptomatic hypoglycemia with Gla-300. Compared with the overall population, the subgroup aged ≥75 years had a more apparent lower risk of hypoglycemia with Gla-300 versus Gla-100. The annualized rates of documented symptomatic were significantly lower with Gla-300 (Gla-300, 1.12 versus Gla-100, 2.71; rate ratio, 0.45).

"Gla-300 demonstrated good efficacy and safety in older people with type 2 diabetes, particularly in those of advanced age (≥75 years)," the authors write.

Several authors disclosed ties to pharmaceutical companies, including Sanofi, which funded the study and the clinical trial considered in the analysis.

Explore further: Severe hypoglycemia rates have equilibrated for DCCT groups

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Severe hypoglycemia rates have equilibrated for DCCT groups

June 7, 2017
(HealthDay)—Rates of severe hypoglycemia have equilibrated between the two Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) treatment groups in association ...

Mini-dose glucagon may halt post-exercise hypoglycemia

May 30, 2018
(HealthDay)—Mini-dose glucagon (MDG) is an effective approach for preventing exercise-induced hypoglycemia in patients with type 1 diabetes, according to a study published online May 18 in Diabetes Care.

Studies compare types of insulin for reducing episodes of low blood sugar for patients with Type 1 or 2 diabetes

July 3, 2017
Treatment with the insulin degludec compared to glargine U100 for 32 weeks resulted in a reduced rate of hypoglycemic (low blood sugar) episodes among patients with type 1 or 2 diabetes and at least one risk factor for hypoglycemia, ...

Insulin glargine 300 U/mL beats glargine 100 U/mL in T1DM

January 31, 2017
(HealthDay)—For patients with type 1 diabetes, receipt of insulin glargine 300 U/mL (Gla-300) is associated with better glucose control than glargine 100 U/mL (Gla-100), regardless of injection time, according to a study ...

Differences in arrhythmic risk in nocturnal, daytime hypoglycemia

February 28, 2017
(HealthDay)—For young adults with type 1 diabetes, there are differences in arrhythmic risk and cardiac repolarization during nocturnal versus daytime hypoglycemia, according to a study published online Feb. 17 in Diabetes ...

Dual-hormone system may lower time in hypoglycemia in T1DM

May 16, 2018
(HealthDay)—For physically active adults with type 1 diabetes, the addition of glucagon delivery to a closed-loop system using wearable sensors with automated exercise detection is associated with reduced hypoglycemia, ...

Recommended for you

Genomic study brings us closer to precision medicine for type 2 diabetes

September 21, 2018
Most patients diagnosed with type 2 diabetes are treated with a "one-size-fits-all" protocol that is not tailored to each person's physiology and may leave many cases inadequately managed. A new study by scientists at the ...

High gluten diet in pregnancy linked to increased risk of diabetes in children

September 19, 2018
A high gluten intake by mothers during pregnancy is associated with an increased risk of their child developing type 1 diabetes, suggests a study published by The BMJ today.

Anti-inflammatory protein promotes healthy gut bacteria to curb obesity

September 19, 2018
Scientists from the UNC School of Medicine discovered that the anti-inflammatory protein NLRP12 normally helps protect mice against obesity and insulin resistance when they are fed a high-fat diet. The researchers also reported ...

Study reveals the current rates of diagnosed type 1 and type 2 diabetes in American adults

September 18, 2018
A new study from the University of Iowa finds that type 2 diabetes remains overwhelmingly the most common type of diabetes diagnosed in American adults who have the disease.

Research reveals link between immunity, diabetes

September 14, 2018
When it comes to diet-induced obesity, your immune system is not always your friend.

BPA exposure in U.S.-approved levels may alter insulin response in non-diabetic adults

September 14, 2018
In a first study of its kind study, researchers have found that a common chemical consumers are exposed to several times a day may be altering insulin release. Results of the study, led by scientists at the University of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.